1. Home
  2. GDOT vs ODTX Comparison

GDOT vs ODTX Comparison

Compare GDOT & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Dot Corporation $0.001 par value

GDOT

Green Dot Corporation $0.001 par value

HOLD

Current Price

$13.53

Market Cap

755.0M

Sector

Finance

ML Signal

HOLD

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$20.78

Market Cap

875.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDOT
ODTX
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
755.0M
875.1M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
GDOT
ODTX
Price
$13.53
$20.78
Analyst Decision
Sell
Analyst Count
2
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
359.2K
177.5K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$2,080,491,000.00
N/A
Revenue This Year
$11.07
N/A
Revenue Next Year
$5.69
N/A
P/E Ratio
$40.76
N/A
Revenue Growth
20.69
N/A
52 Week Low
$10.10
$15.10
52 Week High
$15.41
$23.03

Technical Indicators

Market Signals
Indicator
GDOT
ODTX
Relative Strength Index (RSI) 56.94 54.42
Support Level $12.77 $15.10
Resistance Level $13.73 N/A
Average True Range (ATR) 0.32 1.70
MACD 0.01 0.19
Stochastic Oscillator 91.83 49.67

Price Performance

Historical Comparison
GDOT
ODTX

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for todays workforce.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: